In addition, the study includes applying and validating the new NIA/Alzheimer's Association diagnostic criteria for MCI due to Alzheimer's (Albert, et al., 2011; Alzheimer's & Dementia: The Journal of the Alzheimer's Association) and determining an appropriate set of cognitive tests that would work effectively in all study sites around the globe by taking into account, for example, language and cultural differences.
"Since this is an international trial, with sites in the U.S., Europe, Australia and Russia, it is vitally important that we apply standards that can be used and validated seamlessly around the world," said Welsh-Bohmer. "This study is meant to operationalize the NIA/Alzheimer's Association diagnostic criteria, which represent new standards."
"The new procedures under development for this trial may serve as useful tools for application in other global trials to prevent the onset of symptomatic Alzheimer's," she added.
About AAIC The Alzheimer's Association International Conference (AAIC) is the world's largest conference of its kind, bringing together researchers from around the world to report and discuss groundbreaking research and information on the cause, diagnosis, treatment and prevention of Alzheimer's disease and related disorders. As a part of the Alzheimer's Association's research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community.About the Alzheimer's Association The Alzheimer's Association is the world's leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. Visit www.alz.org or call 800.272.3900. SOURCE Alzheimer's Association